Purpose: A scoping review was conducted to assess the toxicity and safety of <i>Ganoderma lucidum</i>.Methods: A literature search was conducted in several medical databases (EMBASE, Scopus, PubMed, Cochrane Library, ScieneON, and RISS) to identify studies related to <i>G. lucidum</i>. We extracted clinical manifestations of adverse events described in the included studies and analyzed whether the incidence of each adverse event was higher in the <i>G. lucidum</i> group compared to the placebo group.Results: An initial search yielded 1,409 studies, of which 31 studies met the criteria and included in the final analysis (7 randomized controlled trials, 5 nonrandomized studies, and 19 case reports). Several gastrointestinal, respiratory, neurological, and dermatological manifestations were reported as adverse events in the included literature. However, no serious adverse events with a causal relationship to <i>G. lucidum</i> were reported in studies other than case reports, and no statistically significant differences in the incidence of any adverse events were observed between the <i>G. lucidum</i> group and the placebo group (p>0.05).Conclusion: Our findings do not seem to support the claim that <i>G. lucidum</i> poses a safety risk when consumed as food or as an ingredient in food. However, given the existence of some adverse events where a causal link to <i>G. lucidum</i> cannot be entirely ruled out, further research and ongoing monitoring are still warranted.